Monitoring response to a clinically relevant IDH inhibitor in glioma—Hyperpolarized 13C magnetic resonance spectroscopy approaches

Donghyun Hong(University of California, San Francisco), Sabrina M. Ronen(University of California, San Francisco)

Neuro-Oncology Advances

January 1, 2023

10.1093/noajnl/vdad143

Cited by 6

Related Papers

Non-invasive in vivo assessment of IDH1 mutational status in glioma

|Nature Communications|2013|142

PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

|Scientific Reports|2019|64

17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2

|Breast Cancer Research|2010|31

Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1Tesla

|Neuro-Oncology|2012|20